Routinely bundled into executive screening packages, and one of the very few items in that bundle carrying an unambiguous population-level recommendation. Modern treatment converts HIV from a fatal illness into one compatible with normal life expectancy, and effective treatment also prevents onward transmission — so the test changes outcomes both for the person tested and for people who were never tested.
Owens DK, Davidson KW, et al. (US Preventive Services Task Force) “Screening for HIV Infection.” JAMA 2019;321:2326–2336 issues a Grade A recommendation for screening adolescents and adults aged 15 to 65 regardless of individual risk assessment, with one test sufficient for most people. Grade A is the strongest classification the task force awards, and almost nothing else marketed as “longevity screening” carries one.
Owens DK, et al. JAMA. 2019. PubMed: PMID 31184701
Singapore guidance
Not covered in the current review
Singapore’s national screening committee has not reviewed this test in the current volume of its report, which covers nine conditions. That is not a verdict either way.
Source: Screening Test Review Committee report 2026, Volume 1 (Academy of Medicine Singapore and Ministry of Health, February 2026). The full national list · How this is used.
What you would actually pay
- Healthier SG
- Not subsidised
- MediSave
- Not among the screenings named for outpatient claims
Source: Healthier SG Screening (HealthHub) and MediSave outpatient care (Ministry of Health). Absence from either list is not a statement that the test is discouraged — only that no subsidy or claim applies. Gross prices compared.
What it costs when it is wrong
- Basis
- No published harm criterion found
- Severity
- Not documented
Not covered in the current volume of the committee’s report, so no harm criterion was found either way.
An empty finding, not a clean bill of health: this means nothing documented was found for this test. It is not a claim that the test is safe.
Screening harm is not only a laboratory question: the committee’s own criteria advise against a test when “the screening test, or follow-up tests arising from a positive screen, are associated with significant medical risks”. Sources on overdiagnosis → · How this is graded.
FAQ
Is the HIV Screening worth doing in Singapore?
Judged for screening an asymptomatic adult, HIV Screening grades strong on our rubric. It is most appropriate for every adult aged 15–65, at least once. It typically costs S$25–60 in Singapore. The usual schedule: at least once between 15 and 65; more often with ongoing exposure risk.
Weighing this against something else? Compare it with two other tests → · Price it inside a panel →